Clinical simulation built for phase transitions, not dashboards.
ClinicalSim is Bajpai Labs' drug outcome simulation platform: PK/PD modeling, toxicity prediction, and trial success probability before expensive Phase II and Phase III enrollment begins.
Get teams to the right phase transition decisions faster.
ClinicalSim exists because most clinical programs commit Phase II and Phase III capital without quantifying safety risk, dose redundancy, or success probability under real patient variability. We replace assumptions with calibrated simulation.
Quantify DILI risk, dose-response, and trial success probability before capital is committed. Every simulation is scoped to a phase transition decision your team actually faces.
From Phase I PK through virtual trial Monte Carlo and regulatory briefing: one integrated simulation pipeline with a decision-ready deliverable, not disconnected pharmacometric reports.
Typical engagements deliver in 3–5 weeks with FDA-ready documentation. Built for programs that cannot wait until a Phase II hold to discover the problem.
Every engagement returns probability estimates plus the model assumptions, sensitivity analysis, and board deck your clinical development team needs for go/no-go decisions.
Bridge pharmacometrics and commercial drug development.
“Enable clinical development teams to commit capital only to trials that simulation says are worth running, by quantifying safety, dose, and success risk before the first patient is enrolled.”
The principles behind every simulation run.
- Probabilities over power calculations
A quantified 73% success probability with sensitivity bounds beats an 80% power assumption every time.
- Production accountability
Simulation output with full model documentation and regulatory addenda. Not abstract pharmacometric exercises.
- Clinical-calibrated methods
Published PK/PD techniques composed with proprietary calibration from observed Phase II and Phase III outcomes.
- Senior-led engagement
Direct access to the pharmacometricians who built the models, from scoping through board presentation.
A product from a research-driven AI lab.
ClinicalSim is one of Bajpai Labs' specialized platforms, alongside flagship products in computational drug discovery, enterprise AI, and hybrid computing. The same research depth and production accountability that drives the parent lab drives every ClinicalSim engagement.